bromodeoxyuridine has been researched along with levetiracetam in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Menachem, E; Boon, P; Kuhn, HG; Paulson, L; Persson, A; Raedt, R; Van Dycke, A; Vonck, K | 1 |
| Kato, N; Kudo, K; Maru, E; Shibasaki, T; Sugaya, Y | 1 |
2 other study(ies) available for bromodeoxyuridine and levetiracetam
| Article | Year |
|---|---|
Effect of levetiracetam on hippocampal protein expression and cell proliferation in rats.
Topics: Animals; Anticonvulsants; Bromodeoxyuridine; Cell Proliferation; Databases, Protein; Electrophoresis, Gel, Two-Dimensional; Female; Gene Expression Regulation; Hippocampus; Levetiracetam; Mass Spectrometry; Multivariate Analysis; Piracetam; Principal Component Analysis; Rats; Rats, Sprague-Dawley | 2010 |
Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus.
Topics: Animals; Animals, Newborn; Bromodeoxyuridine; Dentate Gyrus; Disease Models, Animal; Electroencephalography; Homeodomain Proteins; Immunohistochemistry; Kainic Acid; Levetiracetam; Neurons; Nootropic Agents; Piracetam; Rats; Seizures; Status Epilepticus; Tetanus Toxin; Time Factors; Tumor Suppressor Proteins | 2010 |